Arbuckle Stuart A 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Feb 12, 2025
Insider Transaction Report
Form 4
Arbuckle Stuart A
EVP\Chief Commercial Officer
Transactions
- Tax Payment
Common Stock
2025-02-10$467.98/sh−3,220$1,506,896→ 69,543 total
Holdings
- 140(indirect: By 401(k))
Common Stock